← Evidence map

ReviewCureus2024

Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies.

Mihaela AndreescuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38344573